LOX and renal carcinoma: Although several studies have shown that LOX inhibitors/knockout effectively inhibit ferroptosis in various disease models [137, 144], study have also reported that LOX inhibitors/knockout failed to inhibit RSL3-induced ferroptosis in renal carcinoma cells [44].